Clinical Trial: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy Adult Participants
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09 With an 84-day Period of
Brief Summary:
This is a randomized, double-blind, placebo-controlled, multiple dose trial of TBD09, administered to healthy adult participants to assess safety, tolerability, and pharmacokinetics up to 84 days of fixed daily dosing of TBD09.The trial will be conducted with two cohorts, with participants enrolled in parallel and randomized to receive either TBD09 or placebo.
Read more